Basilea Pharmaceutica AG

BPMUF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$120,700$59,900$84,700$53,700
Short-Term Investments$0$51,833$0$95,000
Receivables$56,576$27,891$56,552$24,947
Inventory$31,609$26,410$24,244$22,783
Other Curr. Assets$12,026$37,911$9,868$44,636
Total Curr. Assets$220,911$152,145$175,364$241,066
Property Plant & Equip (Net)$19,000$20,552$21,600$2,900
Goodwill$0$0$0$0
Intangibles$374$548$578$632
Long-Term Investments$0$0$23,266-$92,610
Tax Assets$17,333$0-$23,266$95,000
Other NC Assets$146$44$23,306$279
Total NC Assets$36,853$21,144$45,484$6,201
Other Assets$0$0$0$0
Total Assets$257,764$173,289$220,848$247,267
Liabilities
Payables$11,487$5,847$191$10,617
Short-Term Debt$2,062$17,515$39,455$124,401
Tax Payable$0$0$1,000$1,500
Deferred Revenue$0$0$27,133$33,833
Other Curr. Liab.$32,009$24,230$7,071$4,057
Total Curr. Liab.$45,558$47,592$74,850$174,408
LT Debt$109,609$111,091$147,683$94,554
Deferred Rev, NC$11,385$9,460$10,693$11,926
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$10,213$15,148$32,630$24,986
Total NC Liab.$131,207$135,699$191,006$131,466
Other Liabilities$0$0$0$0
Cap. Leases$15,759$17,698$18,311$906
Total Liabilities$176,765$183,291$265,856$305,874
Equity
Pref Stock$0$10,211$3,785$0
Common Stock$13,170$13,100$13,093$12,992
Retained Earnings-$923,293-$1,000,886-$1,035,366-$1,023,219
AOCI-$4,743-$10,211-$3,785-$21,617
Other Equity$995,865$977,784$977,265$973,237
Total Equity$80,999-$10,002-$45,008-$58,607
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$257,764$173,289$220,848$247,267
Net Debt-$9,029$68,706$102,438$165,255
Basilea Pharmaceutica AG (BPMUF) Financial Statements & Key Stats | AlphaPilot